
Dr Asma Patel
Dr Asma Patel is a pharmaceutical development leader with more than 20 years of experience spanning pre-formulation, formulation development, clinical manufacturing and pharmaceutical product strategy across academia, industry and contract development and manufacturing organisations. Her expertise encompasses a broad range of dosage forms and formulation approaches, with a particular focus on addressing bioavailability challenges associated with poorly soluble compounds.
At Quotient Sciences, Dr Patel leads global commercial and scientific consulting activities for drug product development, partnering with biotech and pharmaceutical companies to design phase-appropriate development strategies that balance clinical objectives, manufacturability and long-term programme success. She works closely with clients to guide critical formulation, development and manufacturing decisions from early development through late-stage clinical and commercial programmes.
ArticlePoor solubility as a programme-level risk: selecting formulations for clinical performance and scalable development
In this whitepaper, explore how human pharmacokinetic data can guide formulation decisions, minimise development risk and help teams select the simplest viable approach for poorly soluble molecules.


